Unknown

Dataset Information

0

Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli.


ABSTRACT:

Objectives

To determine whether the spectrum of mutations in marR in ciprofloxacin-resistant clinical isolates of Escherichia coli shows evidence of selection bias, either to reduce fitness costs, or to increase drug resistance. MarR is a repressor protein that regulates, via MarA, expression of the Mar regulon, including the multidrug efflux pump AcrAB-TolC.

Methods

Isogenic strains carrying 36 different marR alleles identified in resistant clinical isolates, or selected for resistance in vitro, were constructed. Drug susceptibility and relative fitness in growth competition assays were measured for all strains. The expression level of marA, and of various efflux pump components, as a function of specific mutations in marR, was measured by qPCR.

Results

The spectrum of genetic alterations in marR in clinical isolates is strongly biased against inactivating mutations. In general, the alleles found in clinical isolates conferred a lower level of resistance and imposed a lower growth fitness cost than mutations selected in vitro. The level of expression of MarA correlated well with the MIC of ciprofloxacin. This supports the functional connection between mutations in marR and reduced susceptibility to ciprofloxacin.

Conclusions

Mutations in marR selected in ciprofloxacin-resistant clinical isolates are strongly biased against inactivating mutations. Selection favours mutant alleles that have the lowest fitness costs, even though these cause only modest reductions in drug susceptibility. This suggests that selection for high relative fitness is more important than selection for increased resistance in determining which alleles of marR will be selected in resistant clinical isolates.

SUBMITTER: Praski Alzrigat L 

PROVIDER: S-EPMC5890708 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli.

Praski Alzrigat Lisa L   Huseby Douglas L DL   Brandis Gerrit G   Hughes Diarmaid D  

The Journal of antimicrobial chemotherapy 20171101 11


<h4>Objectives</h4>To determine whether the spectrum of mutations in marR in ciprofloxacin-resistant clinical isolates of Escherichia coli shows evidence of selection bias, either to reduce fitness costs, or to increase drug resistance. MarR is a repressor protein that regulates, via MarA, expression of the Mar regulon, including the multidrug efflux pump AcrAB-TolC.<h4>Methods</h4>Isogenic strains carrying 36 different marR alleles identified in resistant clinical isolates, or selected for resi  ...[more]

Similar Datasets

| S-EPMC5400412 | biostudies-literature
| S-EPMC7238749 | biostudies-literature
| S-EPMC4776012 | biostudies-literature
| S-EPMC7729382 | biostudies-literature
| S-EPMC3514110 | biostudies-literature
| S-EPMC5516121 | biostudies-literature
| S-EPMC14717 | biostudies-literature
| S-EPMC9177976 | biostudies-literature
2023-05-06 | PXD042036 |
| S-EPMC6194505 | biostudies-literature